Why the study?
Does biphasic PFA prevent chronic histopathologic esophageal changes compared to RFA in a porcine model of esophageal injury?
Does biphasic PFA prevent chronic histopathologic esophageal changes compared to RFA in a porcine model of esophageal injury?
In a porcine model, biphasic PFA appears safer for the esophagus than RFA, causing no chronic histopathologic changes.
Biphasic PFA may avoid chronic esophageal injury versus RFA in ablation; leaves open confirmation of clinical safety in human trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Koruth et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: